US Stock MarketDetailed Quotes

CPIX Cumberland Pharmaceuticals

Watchlist
  • 1.120
  • -0.020-1.75%
Close Nov 18 16:00 ET
  • 1.120
  • 0.0000.00%
Post 20:01 ET
15.73MMarket Cap-1471P/E (TTM)

Cumberland Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-61.55%475.5K
-116.34%-855.66K
-50.66%-2.14M
-27.91%6.09M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
94.41%8.45M
149.80%3.64M
Net income from continuing operations
-44.56%-1.54M
-227.89%-1.1M
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
-56.82%-5.65M
36.67%-2.46M
Operating gains losses
----
----
----
--20.26K
----
----
----
----
----
----
Depreciation and amortization
-5.75%1.4M
-4.84%1.42M
0.56%1.44M
8.30%5.77M
165.65%1.36M
-3.74%1.49M
-7.49%1.5M
-13.66%1.43M
15.67%5.33M
-52.51%511.48K
Other non cash items
-3.50%-798.66K
-111.38%-179.37K
83.38%-355.84K
19.06%-1.71M
67.96%-373.41K
11.39%-771.65K
334.80%1.58M
-459.95%-2.14M
37.69%-2.11M
6.66%-1.17M
Change In working capital
-11.37%1.33M
-189.05%-1.07M
-44.00%-1.39M
-55.61%4.63M
-56.24%2.9M
-31.64%1.5M
-56.71%1.2M
16.36%-967.33K
27.63%10.44M
25.30%6.62M
-Change in receivables
666.56%309.14K
-271.63%-795.18K
-321.42%-1.07M
155.68%3.4M
21.54%2.51M
97.95%-54.56K
-79.23%463.31K
106.21%481.61K
-211.19%-6.12M
-30.41%2.07M
-Change in inventory
-126.28%-170.95K
1,073.11%1.07M
152.69%170.47K
-102.54%-23.14K
-3.20%-441.5K
140.39%650.47K
-86.51%91.45K
-114.24%-323.56K
-81.08%911.08K
-118.92%-427.8K
-Change in payables and accrued expense
-16.99%1.26M
-185.82%-1.28M
41.59%-645.54K
-74.38%3.72M
-68.37%1.82M
-63.19%1.52M
655.79%1.49M
-124.77%-1.11M
2,018.72%14.54M
172.09%5.76M
-Change in other current assets
144.36%598.03K
-48.47%219.07K
-46.40%205.62K
-90.47%65.68K
73.06%-987.75K
-92.18%244.73K
-56.94%425.09K
59.93%383.61K
2,037.87%689.26K
-120.46%-3.67M
-Change in other current liabilities
22.36%-664.19K
77.43%-286.56K
85.86%-57.1K
-704.49%-2.54M
-100.27%-7.71K
-9.08%-855.5K
3.57%-1.27M
-8.76%-403.74K
131.23%419.66K
822.73%2.89M
Cash from discontinued investing activities
Operating cash flow
-61.55%475.5K
-116.34%-855.66K
-50.66%-2.14M
-27.91%6.09M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
33.28%8.45M
85.64%3.64M
Investing cash flow
Cash flow from continuing investing activities
299.47%189.64K
51.65%-46.8K
66.65%-58.19K
99.23%-105.7K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2,624.58%-13.67M
-2,291.39%-640.77K
Net PPE purchase and sale
71.06%-15.38K
90.06%-7.18K
61.20%-41.62K
-175.35%-281.27K
-131.70%-48.67K
41.88%-53.14K
47.40%-72.19K
-297.47%-107.26K
1.34%-102.15K
1,797.00%153.53K
Net intangibles purchase and sale
22.41%-32.54K
-60.98%-39.63K
75.35%-16.57K
91.29%-171.78K
97.88%-38.04K
67.01%-41.93K
30.34%-24.62K
-350.60%-67.19K
-685.74%-1.97M
-2,451.73%-1.79M
Net business purchase and sale
----
----
----
--0
----
----
----
----
---13.5M
--0
Net other investing changes
----
----
----
-81.71%347.36K
----
----
----
----
3,513.07%1.9M
295.93%1M
Cash from discontinued investing activities
Investing cash flow
299.47%189.64K
51.65%-46.8K
66.65%-58.19K
99.23%-105.7K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2,624.58%-13.67M
-2,291.39%-640.77K
Financing cash flow
Cash flow from continuing financing activities
39.18%-536.84K
90.55%-309.58K
236.12%2.42M
-260.10%-7.42M
46.52%-1.49M
55.67%-882.6K
-171.12%-3.28M
-145.41%-1.78M
41.98%-2.06M
-278.19%-2.78M
Net issuance payments of debt
--0
100.25%7.45K
2,683.90%3.3M
-384.65%-3.42M
90.73%-138.98K
82.69%-225K
-192.42%-2.92M
-102.55%-127.71K
--1.2M
---1.5M
Net common stock issuance
51.00%-98.82K
17.54%-134.25K
-32.33%-247.61K
29.68%-740.53K
0.36%-188.97K
-168.56%-201.65K
21.80%-162.79K
67.75%-187.12K
24.07%-1.05M
47.49%-189.66K
Net other financing activities
3.93%-438.02K
3.13%-182.78K
56.93%-630.7K
-47.96%-3.27M
-6.23%-1.16M
25.99%-455.94K
---188.68K
-191.98%-1.46M
-1.94%-2.21M
-191.67%-1.09M
Cash from discontinued financing activities
Financing cash flow
39.18%-536.84K
90.55%-309.58K
236.12%2.42M
-260.10%-7.42M
46.52%-1.49M
55.67%-882.6K
-171.12%-3.28M
-145.41%-1.78M
41.98%-2.06M
-278.19%-2.78M
Net cash flow
Beginning cash position
-5.00%17.34M
13.20%18.55M
-7.27%18.32M
-26.93%19.76M
-5.29%18.51M
0.18%18.25M
-5.10%16.39M
-26.93%19.76M
9.24%27.04M
-24.38%19.54M
Current changes in cash
-50.44%128.31K
-165.06%-1.21M
106.73%226.86K
80.28%-1.44M
-186.10%-186.34K
-80.46%258.88K
96.14%1.86M
65.50%-3.37M
-418.44%-7.28M
-81.93%216.43K
End cash Position
-5.64%17.46M
-5.00%17.34M
13.20%18.55M
-7.27%18.32M
-7.27%18.32M
-5.29%18.51M
0.18%18.25M
-5.10%16.39M
-26.93%19.76M
-26.93%19.76M
Free cash flow
-62.54%427.59K
-117.56%-902.46K
-37.81%-2.19M
-11.58%5.64M
-52.26%953.4K
-52.77%1.14M
138.12%5.14M
-727.80%-1.59M
6.54%6.38M
6.22%2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -61.55%475.5K-116.34%-855.66K-50.66%-2.14M-27.91%6.09M-71.41%1.04M-53.08%1.24M124.64%5.24M-842.34%-1.42M94.41%8.45M149.80%3.64M
Net income from continuing operations -44.56%-1.54M-227.89%-1.1M-1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K-56.82%-5.65M36.67%-2.46M
Operating gains losses --------------20.26K------------------------
Depreciation and amortization -5.75%1.4M-4.84%1.42M0.56%1.44M8.30%5.77M165.65%1.36M-3.74%1.49M-7.49%1.5M-13.66%1.43M15.67%5.33M-52.51%511.48K
Other non cash items -3.50%-798.66K-111.38%-179.37K83.38%-355.84K19.06%-1.71M67.96%-373.41K11.39%-771.65K334.80%1.58M-459.95%-2.14M37.69%-2.11M6.66%-1.17M
Change In working capital -11.37%1.33M-189.05%-1.07M-44.00%-1.39M-55.61%4.63M-56.24%2.9M-31.64%1.5M-56.71%1.2M16.36%-967.33K27.63%10.44M25.30%6.62M
-Change in receivables 666.56%309.14K-271.63%-795.18K-321.42%-1.07M155.68%3.4M21.54%2.51M97.95%-54.56K-79.23%463.31K106.21%481.61K-211.19%-6.12M-30.41%2.07M
-Change in inventory -126.28%-170.95K1,073.11%1.07M152.69%170.47K-102.54%-23.14K-3.20%-441.5K140.39%650.47K-86.51%91.45K-114.24%-323.56K-81.08%911.08K-118.92%-427.8K
-Change in payables and accrued expense -16.99%1.26M-185.82%-1.28M41.59%-645.54K-74.38%3.72M-68.37%1.82M-63.19%1.52M655.79%1.49M-124.77%-1.11M2,018.72%14.54M172.09%5.76M
-Change in other current assets 144.36%598.03K-48.47%219.07K-46.40%205.62K-90.47%65.68K73.06%-987.75K-92.18%244.73K-56.94%425.09K59.93%383.61K2,037.87%689.26K-120.46%-3.67M
-Change in other current liabilities 22.36%-664.19K77.43%-286.56K85.86%-57.1K-704.49%-2.54M-100.27%-7.71K-9.08%-855.5K3.57%-1.27M-8.76%-403.74K131.23%419.66K822.73%2.89M
Cash from discontinued investing activities
Operating cash flow -61.55%475.5K-116.34%-855.66K-50.66%-2.14M-27.91%6.09M-71.41%1.04M-53.08%1.24M124.64%5.24M-842.34%-1.42M33.28%8.45M85.64%3.64M
Investing cash flow
Cash flow from continuing investing activities 299.47%189.64K51.65%-46.8K66.65%-58.19K99.23%-105.7K140.68%260.64K-113.96%-95.07K43.91%-96.81K98.71%-174.45K-2,624.58%-13.67M-2,291.39%-640.77K
Net PPE purchase and sale 71.06%-15.38K90.06%-7.18K61.20%-41.62K-175.35%-281.27K-131.70%-48.67K41.88%-53.14K47.40%-72.19K-297.47%-107.26K1.34%-102.15K1,797.00%153.53K
Net intangibles purchase and sale 22.41%-32.54K-60.98%-39.63K75.35%-16.57K91.29%-171.78K97.88%-38.04K67.01%-41.93K30.34%-24.62K-350.60%-67.19K-685.74%-1.97M-2,451.73%-1.79M
Net business purchase and sale --------------0-------------------13.5M--0
Net other investing changes -------------81.71%347.36K----------------3,513.07%1.9M295.93%1M
Cash from discontinued investing activities
Investing cash flow 299.47%189.64K51.65%-46.8K66.65%-58.19K99.23%-105.7K140.68%260.64K-113.96%-95.07K43.91%-96.81K98.71%-174.45K-2,624.58%-13.67M-2,291.39%-640.77K
Financing cash flow
Cash flow from continuing financing activities 39.18%-536.84K90.55%-309.58K236.12%2.42M-260.10%-7.42M46.52%-1.49M55.67%-882.6K-171.12%-3.28M-145.41%-1.78M41.98%-2.06M-278.19%-2.78M
Net issuance payments of debt --0100.25%7.45K2,683.90%3.3M-384.65%-3.42M90.73%-138.98K82.69%-225K-192.42%-2.92M-102.55%-127.71K--1.2M---1.5M
Net common stock issuance 51.00%-98.82K17.54%-134.25K-32.33%-247.61K29.68%-740.53K0.36%-188.97K-168.56%-201.65K21.80%-162.79K67.75%-187.12K24.07%-1.05M47.49%-189.66K
Net other financing activities 3.93%-438.02K3.13%-182.78K56.93%-630.7K-47.96%-3.27M-6.23%-1.16M25.99%-455.94K---188.68K-191.98%-1.46M-1.94%-2.21M-191.67%-1.09M
Cash from discontinued financing activities
Financing cash flow 39.18%-536.84K90.55%-309.58K236.12%2.42M-260.10%-7.42M46.52%-1.49M55.67%-882.6K-171.12%-3.28M-145.41%-1.78M41.98%-2.06M-278.19%-2.78M
Net cash flow
Beginning cash position -5.00%17.34M13.20%18.55M-7.27%18.32M-26.93%19.76M-5.29%18.51M0.18%18.25M-5.10%16.39M-26.93%19.76M9.24%27.04M-24.38%19.54M
Current changes in cash -50.44%128.31K-165.06%-1.21M106.73%226.86K80.28%-1.44M-186.10%-186.34K-80.46%258.88K96.14%1.86M65.50%-3.37M-418.44%-7.28M-81.93%216.43K
End cash Position -5.64%17.46M-5.00%17.34M13.20%18.55M-7.27%18.32M-7.27%18.32M-5.29%18.51M0.18%18.25M-5.10%16.39M-26.93%19.76M-26.93%19.76M
Free cash flow -62.54%427.59K-117.56%-902.46K-37.81%-2.19M-11.58%5.64M-52.26%953.4K-52.77%1.14M138.12%5.14M-727.80%-1.59M6.54%6.38M6.22%2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Cannabis & Hemp
Cannabis & Hemp
Intraday-0.29%